Received May 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | — | — |
bad headaches; long covid symptoms; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A 54-year-old male patient received BNT162b2 (BNT162B2), on 30May2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE), administration date: 09May2021, for Covid-19 Immunization, reaction(s): "headaches", "chills", "insomnia". The following information was reported: HEADACHE (life threatening), outcome "unknown", described as "bad headaches"; POST-ACUTE COVID-19 SYNDROME (non-serious), outcome "unknown", described as "long covid symptoms". Clinical course: The patient had side effects like headaches, chills, insomnia & many other side effects. The patient had previously received the unspecified Pfizer vaccine "RM" (as reported) and experienced coughing, insomnia, shortness of breath, headaches, depression, anxiety (severe). It was reported that the patient bad headaches, as a result of taking the covid vaccines. The patient also had long covid symptoms because of the shots. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202500034218 same patient, different vaccine dose/event;US-PFIZER INC-202500099734 same patient, different vaccine dose/event;